B of A Securities Rates ICON Public (ICLR) sell
B of A Securities maintains a sell rating on ICON PLC with a $150 price target, a 11.69% downside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
B of A Securities rated ICON Public Limited Company ($ICLR) "sell" with a $150 price target on June 25, 2026.
Since the rating, $ICLR is up 7.5% after 1 week, up 4.9% after 1 month and up 5.7% to date (from the $160.96 close on Jun 25, 2026).
ICLR
ICON Public Limited Company
Key Points
- B of A Securities reiterated its sell rating on ICON Public Limited Company (ICLR) with a price target of $150.
- B of A Securities's $150 price target implies 11.69% downside from ICON Public Limited Company's ($ICLR) current $169.86 share price.
- ICON shares traded at $158.17 on Thursday, with a market cap of approximately $10.78 billion and a forward P/E of 12.03.
- Several insiders, including Dr. John Climax, engaged in buying and selling shares on May 14, 2026.
Get $ICLR trade alerts by text
We text you when insiders, Congress or big funds trade $ICLR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated ICON Public Limited Company alert may contain errors. Disclosures
B of A Securities reiterated its sell rating on ICON Public Limited Company (NASDAQ: ICLR) on June 25, 2026. The firm, represented by analyst Michael Ryskin, set a price target of $150. Shares of ICON traded at $158.17 on Thursday.
B of A Securities vs. the S&P 500
Hypothetical returns from B of A Securities's disclosed trades, not real profit or advice. How we model this.
ICON Public Limited Company Stock Up 3.5%
Shares of ICON Public Limited Company traded near $158.17 on Thursday. The company has a market cap of about $10.78 billion and a P/E ratio of 48.36. Its forward P/E is 12.03, and it has a beta of 1.271, indicating some volatility compared to the market. The 52-week range for ICON's stock is between $66.57 and $211.00, with a 50-day moving average of $124.49 and a 200-day moving average of $149.71.
$ICLR price target
ICON Public Limited Company daily closes and this analyst's $150 target. Not advice.
Insider Buying and Selling at ICON Public Limited Company
Several insiders were active in trading ICON shares on May 14, 2026. Dr. John Climax bought and sold 5,005 shares, while Ronan Martin Murphy also participated in similar transactions. Eugene Pacelli McCague was involved in buying and selling 3,255 shares.
Analysts Set New Price Targets
On June 25, 2026, B of A Securities maintained its sell rating on ICON with a $150 price target. Baird also maintained its buy rating with a target of $186. Barclays kept a hold rating with a $160 target on June 24. The consensus among 16 analysts is a buy rating with an average target price of $154.19.
About ICON Public Limited Company
ICON Public Limited Company is a clinical research organization based in Dublin, Ireland. It offers development and commercialization services to the healthcare industry, including pharmaceutical, biotechnology, and medical device sectors. The company supports various stages of clinical development, from early-phase trials to post-market commercialization. ICON employs around 40,100 people and is led by CEO Barry Balfe.
Bottom Line
B of A Securities' reiterated sell rating on ICON highlights the firm's cautious stance despite the company's broad service offerings in the clinical research space. ICON's stock has shown volatility, with a significant 52-week range. Investors should consider this 13F filing as a historical snapshot of analyst sentiment and not necessarily indicative of future performance.
Related Filing Alerts
Source: B of A Securities's rating change on $ICLR (Jun 25, 2026). Written by software, not financial advice. How we make alerts